ZBIO   $20.83  0.34% Market Closed After Close 20.8 -0.14%

Zenas BioPharma, Inc.
Total Cash 183.93M
totalCashPerShare 13.42
EBITDA -56.31M
Total Debt 508.00K
quickRatio 4.703
currentRatio 4.823
Total Revenue 50.00M
debtToEquity 0.316
Revenue/Share 3.714
ROA
ROE
grossProfits
freeCashflow
operatingCashflow -33.62M
earningsGrowth
revenueGrowth
grossMargins -0.72446
ebitdaMargins -1.12624
operatingMargins -1.12872
profitMargins -1.09514
enterpriseValue 546.74M
forwardPE
floatShares 8.85M
sharesOutstanding 41.78M
sharesShort 230.55K
sharesShortPriorMonth 0.00
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.26%
heldPercentInstitutions 0.39%
Short Ratio help_outline 2.81%
shortPercentOfFloat
impliedSharesOutstanding
bookValue -21.071
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -54.76M
trailingEps -3.90%
forwardEps
enterpriseToEbitda -9.71
lastDividendValue
lastDividendDate
currentQuarterEstimate -13.56
institutionsCount 10
lastUpdated Nov. 2, 2024, 8:07 a.m.